PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 261 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,165,000 | -26.9% | 280,431 | 0.0% | 0.05% | -26.9% |
| Q2 2021 | $9,807,000 | +373.8% | 280,431 | -31.9% | 0.07% | +191.3% |
| Q1 2020 | $2,070,000 | -2.3% | 411,991 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $2,118,000 | +23.9% | 411,991 | +24.3% | 0.02% | 0.0% |
| Q3 2019 | $1,710,000 | -56.0% | 331,355 | -0.6% | 0.02% | -52.1% |
| Q2 2019 | $3,888,000 | +62.3% | 333,355 | +0.6% | 0.05% | +54.8% |
| Q1 2019 | $2,396,000 | +12.7% | 331,355 | +15.3% | 0.03% | -6.1% |
| Q4 2018 | $2,126,000 | – | 287,355 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |